STAT3 and rosacea: Given the documented interactions between STAT3 and other inflammatory pathways such as VEGF and YAP/TAZ in endothelial and epithelial cells [45,52], it is possible that CBG’s suppression of STAT3 contributes to its broader anti-angiogenic and anti-inflammatory effects in rosacea.